Background: Life-long accumulation of irreversible advanced glycation end-products leads to ventricular stiffening. Endurance training preserves left ventricular compliance. The advanced glycation end-product cross-link breaker Alagebrium (ALT) decreases ventricular stiffness in animal studies. We examined the effects of 1-year treatment with ALT on cardiac function in healthy older subjects, and combined it in a factorial design with exercise training (ExT). results: Forty-four subjects (age 70±4 years) completed the 1-year intervention (4 groups, n=11). AlthoughVO2max improved significantly, by 15% (ExT pre 23.9±4.5 vs. post 27.2±4.6 mlO2/min/kg, p<0.001), cardiac function did not improve with 1-year ExT. Preservation of diastolic function was seen in the ALT groups, while the placebo groups showed deterioration of left atrial volume (pre 47±12 post 45±13 ml vs. pre 45±11 post 51±14 ml, respectively, p=0.006), SRA (pre 1.22±0.15 post 1.18±0.18 s-1 vs. pre 1.19±0.23 post 1.27±0.24 s-1, respectively, p=0.075), MVA (pre -6.02±1.03 post -5.78±1.28 cm/s vs. pre -5.41±1.30 vs. post -6.10±0.90 cm/s, respectively, p=0.004) and MVE/MVA ratio (pre 0.70±0.19 post 0.71±0.25 vs. pre 0.86±0.23 post 0.70±0.16, respectively, p=0.002).
conclusion:
One year of exercise training significantly improved physical fitness, however despite the established benefits, exercise did not reverse the effects of sedentary aging. On the other hand, one year treatment with ALT might attenuate the decrease in diastolic function associated with one year of physiological aging.
